Philip E Hansen

USPTO Granted Patents = 10 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 473(Granted Patents)

Location History:

Copenhagen, DK (1986 - 1993)
Holte, DK (1999 - 2016)

Company Filing History:

Years Active: 1986-2016

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9433589 - Injectable pharmaceutical compositions comprising adrenaline and citric acid (2016-09-06),

2. 8518430 - Dry mouldable drug formulation (2013-08-27),

3. 8084053 - Dry mouldable drug formulation (2011-12-27),

4. 7666844 - Dry mouldable drug formulation (2010-02-23),

5. 6660197 - Method for producing an elongated drug formation (2003-12-09),

6. 6485453 - Cassette for storing and insertion of solid medicine (2002-11-26),

7. 6043214 - Method for producing powder formulation comprising an insulin (2000-03-28),

8. 5898028 - Method for producing powder formulation comprising an insulin (1999-04-27),

9. 5179079 - Nasal formulation and intranasal administration therewith (1993-01-12),

10. 4614730 - Stabilized insulin preparations and a process for preparation thereof (1986-09-30),

Title: The Innovations of Philip E. Hansen

Introduction

Philip E. Hansen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on improving the stability and efficacy of injectable pharmaceutical compositions.

Latest Patents

Among his latest patents is an invention titled "Injectable pharmaceutical compositions comprising adrenaline and citric acid." This invention relates to injectable pharmaceutical compositions that demonstrate improved storage stability, specifically those containing adrenaline and citric acid. Another notable patent is for a "Dry mouldable drug formulation," which consists of solid pharmaceutical compositions for parenteral injection. This formulation includes a binder and at least one therapeutic agent, allowing for direct injection without the need for cannulas or similar devices.

Career Highlights

Philip E. Hansen has worked with prominent companies in the pharmaceutical industry, including Novo Nordisk A/S and Novo Industri A/S. His experience in these organizations has contributed to his expertise in developing innovative drug formulations.

Collaborations

Throughout his career, Hansen has collaborated with esteemed colleagues such as Thomas Buch-Rasmussen and James M. Flink. These partnerships have further enhanced his contributions to the field of pharmaceuticals.

Conclusion

Philip E. Hansen's work in the pharmaceutical industry exemplifies innovation and dedication. His patents reflect a commitment to improving drug formulations and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.